Buy Signal Flashing For Struggling Biotech
Biotech Vertex Pharmaceuticals (VRTX) has been struggling on the charts over the past few weeks, putting a dent in its now 10% year-to-date gain. The stock’s 5.6% post-earnings pop earlier this month has already been erased, and VRTX is now trading at its …